首页> 美国卫生研究院文献>Frontiers in Oncology >Mutant p53: One No One and One Hundred Thousand
【2h】

Mutant p53: One No One and One Hundred Thousand

机译:突变体p53:一个一个和十万个

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Encoded by the mutated variants of the TP53 tumor suppressor gene, mutant p53 proteins are getting an increased experimental support as active oncoproteins promoting tumor growth and metastasis. p53 missense mutant proteins are losing their wild-type tumor suppressor activity and acquire oncogenic potential, possessing diverse transforming abilities in cell and mouse models. Whether various mutant p53s differ in their oncogenic potential has been a matter of debate. Recent discoveries are starting to uncover the existence of mutant p53 downstream programs that are common to different mutant p53 variants. In this review, we discuss a number of studies on mutant p53, underlining the advantages and disadvantages of alternative experimental approaches that have been used to describe the numerous mutant p53 gain-of-function activities. Therapeutic possibilities are also discussed, taking into account targeting either individual or multiple mutant p53 proteins in human cancer.
机译:由TP53抑癌基因突变的突变体编码,突变的p53蛋白作为活性癌蛋白可促进肿瘤的生长和转移,从而获得了越来越多的实验支持。 p53错义突变蛋白正在丧失其野生型抑癌活性,并具有致癌潜力,在细胞和小鼠模型中具有多种转化能力。各种突变p53的致癌潜力是否不同一直是一个争论的问题。最近的发现开始发现存在突变p53下游程序,这些程序对于不同的突变p53变体是通用的。在这篇综述中,我们讨论了有关突变型p53的许多研究,强调了替代实验方法的优缺点,该方法已用于描述众多突变型p53的功能获得活性。还讨论了治疗可能性,考虑到靶向人类癌症中的单个或多个突变体p53蛋白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号